2007

1. Ishii, A., H. Sawa, T. Tsujita, K. Shida, A. Matsuo, M. Matsumoto, and T. Seya. 2007. Lamprey Toll-like receptors with properties distinct from those of variable lymphocyte receptors. J. Immunol. 178: 397-406.
2. Niimi, K. K. Asano, Y. Shiraishi, T. Nakajima, M. Wakaki, J. Kagyo, T. Takihara, Y. Suzuki, K. Fukunaga, T. Shiomi, T. Oguma1, K. Sayama, K. Yamaguchi, Y. Natori, M. Matsumoto, T. Seya, and A. Ishizaka. 2007. Toll-like receptor 3-mediated eotaxin-1 release from human bronchial smooth muscle cells. J. Immunol. 178: 489-495.
3. Akazawa T., M. Okuno, Y. Okuda, K. Tsujimura, T. Takahashi, M. Ikawa, M. Okabe, T. Ebihara, M, Shingai, N. Inoue, M. Tanaka-Okamoto, H. Ishizaki, J. Miyoshi, M. Matsumoto, and T. Seya. 2006. Antitumor NK activation induced by the Toll-like receptor3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc. Natl. Acad. Sci. USA. 104: 252-257.
4. Sukenobu, N., K. Hazeki, K. Yoshikawa, T. Yamamoto, U. Kikkawa, M. Matsumoto, T. Seya, and O. Hazeki. 2006. Protein kinase Cd associates TIRAP/Mal and regulates NF-kB and mitogen-activated protein kinases in Toll-like receptor signaling. Molec. Immunol. 44: 2257-2264.
5. Azuma M., A. Matsuo, Y. Fujimoto, K. Fukase, K. Hazeki, O. Hazeki, M. Matsumoto, and T. Seya. 2007. Inhibition of lipid A-mediated type I interferon induction by Bactericidal/peameability-increasing protein (BPI). Biochem. Biophys. Res. Commun. 354: 574-578.
6. Shingai, M., T. Ebihara, N. A. Begum, A. Kato,, T. Honma, K. Matsumoto, H. Saito, H. Ogura, M. Matsumoto, and T Seya. 2007. Differential I interferon (IFN) inducing abilities of wild-type vs. vaccine strains of measles virus. J. Immunol. 179: 6123-6133.
7. Ebihara, T., H. Masuda, T. Akazawa, M. Shingai, H. Kikuta, T. Ariga, M. Matsumoto, and T. Seya. 2007. NKG2D ligands are induced on human dendritic cells by TLR ligand stimulation and RNA virus infection. Int. Immunol.19: 1145-1155 .
8. Ishii, A., M. Kawasaki, M. Matsumoto, S. Tochinai, and T. Seya. 2007. Phylogenetic and expression analysis of amphibian Xenopus Toll-like receptors. Immunogenetics 59: 281-293.
9. Takada, E., S. Okahira, M. Sasai, K. Funami, T. Seya, and M. Matsumoto. 2007. C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission. Molec. Immunol 581: 3334-3340
10. Akazawa T., M. Ikawa, M. Okabe, T. Ebihara, M, Shingai, N. Inoue, M. Matsumoto, and T. Seya. 2007. Tumor regression induced by adoptive transfer of MyD88-transfected dendritic cells in a mouse model. FEBS lett. 581: 3334-3340
11. Yoshioka, M., N. Fukuishi, S. Iriguchi, K. Ohsaki, H. Yamanobe, A. Inukai, D. Kurihara, N. Imajo, Y. Yasui, N. Matsui, T. Tsujita, A. Ishii, T. Seya, M. Takahama, and M. Akagi. 2007. Lipoteichoic acid down-regulates Fce receptor I expression on human mast cells through Toll-like receptor 2. J. Aller. Clin. Immunol. 120: 452-461
12. Shiratori, I., Y.Suzuki, H.Osiumi, N. A. Begum, T. Ebihara, M. Matsumoto, K. Hazeki, K. Kodama, Y. Kashiwazaki, and T. Seya. 2007. Recombinant IL-12/IL-18 therapy in a guinea pig hepatoma cell implanted model.Canser Sci. 98: 1936-1942.
13. Funami K., M. Sasai, Y. Ohba, H. Oshiumi, T. Seya, and M. Matsumoto. 2007. Spatiotemporal mobilization of TICAM-1 in response to dsRNA.J Immunol. 179: 6867-6782.
14. Ayata, M., M. Shingai, X. Ning, M. Matsumoto, T. Seya, S. Otani, T. Seto, S. Oshimoto, and H. Ogura. 2007. Effect of the alterations in the fusion protein of measles virus isolated from brains of patients with subacute sclerosing panencephalitis on syncytium formation.Virus Res. 130: 260-268.
15. Yamazaki, K., k. Suzuki, E. Yamada, T. Yamada, F. Takeshita, M. Matsumoto, T. Mitsuhashi, T. Obara, K. Takano, and K.Sato. 2007. Suppression of iodide uptake and thyroid hormone synthesis with stimulation of the type I interferon system by double-stranded RNA (dsRNA) in cultured human thyroid follicles. Endocrinology. 148: 3226-3235
16. Seya, T., M. Matsumoto, T. Ebihara, and T. Akazawa. 2007. NK-activating dendritic cells are elicited by stimulation with TLR3 ligand. Hirosaki Med. J. 59 (suppl): 43-51.